Reagenzien und Instrumente für die Immunologie Zellbiologie und Molekularbiologie
 

MyBiosource

  Alle Produkte
 
Website: 
https://www.mybiosource.com
 
SARS-CoV-2 - Favipiravir - Therapeutika-Kandidaten

SARS-CoV-2 - Favipiravir - Therapeutika-Kandidaten

Ergebnis Ihrer Suche : 17 Produkt(e) gefunden

Grenzen Sie Ihre Suche ein :

RUOCE / IVD
  • Unconjugated 8
  • Inhibitor/Antagonist/Agonist 11
  • Biochemicals 6
  • Assay 3
FILTER ANWENDEN
REINITIALISIEREN


Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
MBS696243-5x25mg
Favipiravir
 5x25mg 
MBS696243-5mg
Favipiravir
 5mg 
MBS696243-25mg
Favipiravir
 25mg 
MBS3603784-5mg
Favipiravir
 5mg 
MBS3603784-10mg
Favipiravir
 10mg 
MBS3603784-50mg
Favipiravir
 50mg 
MBS3603784-100mg
Favipiravir
 100mg 
MBS3603784-500mg
Favipiravir
 500mg 
MBS3603784-5x500mg
Favipiravir
 5x500mg 
MBS579360-500mg
Favipiravir (T-705)
 500mg 
MBS579360-5x500mg
Favipiravir (T-705)
 5x500mg 
MBS579360
Favipiravir (T-705)
 Onrequest 
MBS386245-5x100mg
T-705 (Favipiravir)
 5x100mg 
MBS386245-100mg
T-705 (Favipiravir)
 100mg 
MBS386245-10mg
T-705 (Favipiravir)
 10mg 
MBS386245-25mg
T-705 (Favipiravir)
 25mg 
MBS386245-50mg
T-705 (Favipiravir)
 50mg 
    ‹
    ›